These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19560596)

  • 61. [Report of a 2-year period of therapeutic experience with ethambutol in pulmonary tuberculosis].
    Jacometta Longarato F
    Friuli Med; 1968; 23(4):579-610. PubMed ID: 5720901
    [No Abstract]   [Full Text] [Related]  

  • 62. Novel drug combination for tuberculosis to be tested across 50 sites.
    Bagcchi S
    BMJ; 2014 May; 348():g3535. PubMed ID: 24868091
    [No Abstract]   [Full Text] [Related]  

  • 63. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 64. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 65. [Cervical spondylodiscitis: one pathogen may hide another].
    Toubiana J; Salomon J; Ader F; Perronne C; Carlier R; Bernard L
    Med Mal Infect; 2006 Jan; 36(1):55-7. PubMed ID: 16309869
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B; Cramer G; Hamel U; Roth G
    Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.
    Alffenaar JW; van Altena R; Bökkerink HJ; Luijckx GJ; van Soolingen D; Aarnoutse RE; van der Werf TS
    Clin Infect Dis; 2009 Oct; 49(7):1080-2. PubMed ID: 19712035
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Doctors report breakthrough antibiotic treatment for TB.
    AIDS Read; 2007 Nov; 17(11):528, 534. PubMed ID: 18167636
    [No Abstract]   [Full Text] [Related]  

  • 69. Possible association of rare polymorphism in the ABCB1 gene with rifampin and ethambutol drug-resistant tuberculosis.
    Rodríguez-Castillo JA; Arce-Mendoza AY; Quintanilla-Siller A; Rendon A; Salinas-Carmona MC; Rosas-Taraco AG
    Tuberculosis (Edinb); 2015 Sep; 95(5):532-7. PubMed ID: 26067842
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of chronic cavernous forms of pulmonary tuberculosis with second-series preparations and ethambutol].
    Mamolat AS; Bialik IB
    Vrach Delo; 1971 Apr; 7():66-70. PubMed ID: 5140135
    [No Abstract]   [Full Text] [Related]  

  • 71. [Initial results of the treatment of pulmonary tuberculosis with ethambutol in adults].
    Fréour P; Tessier R; Monmayou R; Chomy P; Bernadou J; Chidler H; Puissant M
    Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1066-78. PubMed ID: 5622565
    [No Abstract]   [Full Text] [Related]  

  • 72. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 73. [Ethambutol in the therapy of pulmonary tuberculosis. (Case studies)].
    Camurati E; Maggi M; Rossi A
    G Ital Mal Torace; 1968; 22(4):221-6. PubMed ID: 5743004
    [No Abstract]   [Full Text] [Related]  

  • 74. Quantitative bacteriology in the clinical testing of new antituberculosis drugs.
    Wallace AT
    Tubercle; 1969 Mar; 50():Suppl:47-9. PubMed ID: 4990183
    [No Abstract]   [Full Text] [Related]  

  • 75. [Local treatment of pulmonary and extrapulmonary tuberculosis with ethambutol].
    Fossati C
    Clin Ter; 1970 Apr; 53(2):159-68. PubMed ID: 5527642
    [No Abstract]   [Full Text] [Related]  

  • 76. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U; Briccarello L; Vercellino E
    G Ital Mal Torace; 1968; 22(4):195-201. PubMed ID: 5743001
    [No Abstract]   [Full Text] [Related]  

  • 77. Moxifloxacin is an effective and safe candidate agent for tuberculosis treatment: a meta-analysis.
    Xu P; Chen H; Xu J; Wu M; Zhu X; Wang F; Chen S; Xu J
    Int J Infect Dis; 2017 Jul; 60():35-41. PubMed ID: 28495364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ethambutol in the treatment of patients with chronic pulmonary tuberculosis.
    de Mûelenaere MG; Kleeberg HH; MacKintosh J; Behyna E; Glatthaar E
    S Afr Med J; 1971 Feb; 45(7):171-4. PubMed ID: 5553600
    [No Abstract]   [Full Text] [Related]  

  • 79. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 80. Ethambutol in the re-treatment of multi-resistant advanced pulmonary tuberculosis (salvage cases).
    Roy DC; Sen PC; Bajpai BK
    Indian J Chest Dis; 1974 Jul; 16(3):153-62. PubMed ID: 4422083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.